denv-2

NITD008 (7-Deaza-2'-C-acetylene-adenosine) is a potent and selective adenosine nucleoside inhibitor.NITD008 is an adenosine nucleoside analog with broad-spectrum antiviral activity that inhibits dengue, animal cupripoxvirus, and Zika virus.

DENV-2/ZIKV-IN-1 (Compd 16a) is a dual inhibitor of dengue virus (DENV) and Zika virus (ZIKV), exhibiting EC50 values of 1.4 μM and 2.4 μM, respectively.

Denv-in-5 is an effective and selective dengue virus (DENV) inhibitor with EC50 values of 1.47, 9.23, 7.08, 8.91 μM for denV-I-IV and 0.1512 μM for HIV-1IIIB.

ML-SA1 (Mucolipin synthetic agonist 1) is a selective TRPML agonist, inhibits Dengue virus 2 (DENV2) and Zika virus (ZIKV) by promoting lysosomal acidification and protease activity. The IC50 value of ML-SA1 against DENV2 RNA and ZIKV RNA is 8.3 μM and 52.99 μM, respectively[1].

Antiviral Agent 51 (compound A) is a fucoidan and antiviral agent that inhibits Human alphaherpesvirus 1 and interacts with the RNA-dependent RNA polymerase (RdRp) of DENV-2, making it useful for studying dengue virus.

A181 (AI-181) is a DENV-2 inhibitor, suitable for use in dengue fever research.

SMU-1k is a potent broad-spectrum antiviral agent. It exhibits inhibitory activity against ZIKV and DENV-2, with EC50 values of 7.08 μM and 3.96 μM, respectively. SMU-1k significantly suppresses the expression of NS5 protein and restores the levels of STAT2.

DV-B-120 is a competitive inhibitor of the dengue virus (DENV). It inhibits the NS2B-NS3 protease, effectively targeting DENV-1, DENV-2, DENV-3, and DENV-4 with IC50 values of 5.35, 7.39, 10.49, and 8.58 μM, respectively. DV-B-120 exerts its antiviral effects by inhibiting DENV replication.

DENV ligand 2 is a ligand for the DENV E protein. It is used in the synthesis of the PROTAC degrader ZXH-8-004 and serves as the active form of DENV ligand 1.

GNF-2-deg is a PROTAC degrader that targets the envelope protein of the dengue virus (DENV E protein), achieving a DC50 of 0.83 μM. It inhibits viral entry by preventing membrane fusion mediated by the E protein and demonstrates antiviral activity against DENV 2 through protein degradation, with an EC90 of 3.5 μM. Additionally, GNF-2-deg shows antiviral efficacy against ZIKV, JEV, WNV, and YFV, with EC90 values ranging from 1.96 to 7.79 μM.

ZXH-8-004 (2-12-2-deg) is a potent degrader of DENV EPROTAC, with a DC50 of 0.21 µM. Additionally, ZXH-8-004 exhibits antiviral activity.

DENV-IN-15 is a sulfonyl anthranilic acid derivative and a pan-serotype anti-dengue virus (DENV) inhibitor with broad-spectrum RNA virus activity. It has an EC50 of 0.7 μM against DENV-2 in Huh-7 cells. DENV-IN-15 selectively regulates the translation process of mRNA encoding translation-related proteins with a 5' oligopyrimidine motif and reduces the expression of specific ribosomal proteins, thereby inhibiting viral replication. Additionally, DENV-IN-15 enhances membrane permeability, human plasma stability, and human liver microsomal metabolic stability. It is useful for research related to dengue virus infection.

Panduratin A is a natural chalcone derivative with inhibitory activity against MMP-9 in human oral epidermoid carcinoma KB cells; inhibitory activity against the NS3 protease of DENV-2 (Ki=25 μM); significant cytotoxicity against human androgen-independent prostate cancer cells PC-3 and DU-145; and also able to activate the LKB1-AMPK- PPARα /δ signaling pathway and enhance the oxidative capacity of myocyte mitochondria.

(E)-Guggulsterone is an isomer of guggulsterone. As an FXR antagonist, it reduces blood lipids, induces heme oxygenase-1 expression, blocks DENV NS2B/3B activity, and inhibits DENV replication.

LL-37 is a cationic and α-helical antimicrobial peptide expressed in human bone marrow, testis, granulocytes, and gingival epithelium and is upregulated in psoriatic lesions. It inhibits growth of Gram-positive E. coli D21 and Gram-negative B. megatarium in a concentration-dependent manner and LL-37 expression is induced in A549 epithelial cells, alveolar macrophages, neutrophils, and monocyte-derived macrophages following M. tuberculosis infection. LL-37 binds sheep erythrocytes coated with S. minnesota Re-LPS and induces agglutination with a minimal agglutinating concentration (MAC) of 12.1 μg/ml. It is a chemoattractant for, and can induce calcium mobilization in, human monocytes, neutrophils, and T cells that naturally express formyl peptide receptor-like 1 (FPRL1) and FPRL1-transfected HEK293 cells. LL-37 (10-15 μM) pretreatment of dengue virus type 2 (DENV-2) reduces its infectivity as well as levels of viral genomic RNA and NS1 antigen. In vivo, LL-37 inhibits cecal ligation and puncture-induced caspase-1 activation and pyroptosis of peritoneal macrophages, reduces levels of the inflammatory cytokines IL-1β, IL-6, and TNF-α, and improves survival in polybacterial septic mice.

DENV-IN-2 is a highly effective inhibitor of dengue viral replication with a potency indicated by an EC 50 of 0.016 nM. It exhibits significant activity against all four serotypes of the Dengue virus, with EC 50 values ranging from 0.013 to 0.029 nM.

GAK inhibitor 2 (Compound 14g) is a highly potent inhibitor of cyclin G-associated kinase (GAK) with an IC50 of 0.024 μM and exhibits remarkable antiviral activity against dengue virus (DENV) with an EC50 of 1.049 μM [1].

NS2B/NS3-IN-2 is a potent, covalent inhibitor of dengue virus (DENV) NS2B/NS3 with an IC50 of 6.0 nM and a Ki of 0.66 μM. It significantly increases cell viability and exhibits no cytotoxicity.

RK-0404678 is a novel inhibitor of dengue virus NS5 RNA-dependent RNA polymerase (RdRp), inhibiting the DENV type 2 (DENV2) RdRp activities.

DENV-IN-10 is a potent tetravalent inhibitor of the dengue virus, with half-maximal effective concentrations (EC50s) of 1.36, 0.87, 0.94, and 0.95 μM against DENV-1, DENV-2, DENV-3, and DENV-4 serotypes, respectively. Functioning as a post-entry replication inhibitor, DENV-IN-10 demonstrates specificity for primate-origin cells [1].

Antiviral agent 36 (compound 27), a potent inhibitor of both dengue (DENV) and Zika (ZIKV) viruses, demonstrates replication inhibition with EC50 values of 100 nM for ZIKV-FLR, 90 nM for ZIKV-HN16, 210 nM for DENV-2, and 120 nM for DENV-3 [1].

DENV-IN-12 (Compound 6), a derivative of N-methylcytisine thio, effectively inhibits both DENV-1 and DENV-2. It demonstrates strong antiviral activity against DENV-2, with EC50 values between 0.002 and 0.005 μM across various cell lines [1].

NITD-2 is a dengue virus (DENV) polymerase inhibitor, inhibits the DENV RdRp-mediated RNA elongation. NITD-2 penetrates cell membrane poorly. Dengue virus (DENV) is the most prevalent mosquito- borne viral pathogen in humans. Neither vaccine nor antiviral therapy is currently available for DENV.

Glabranine is a natural prenylated flavonoid isolated from Tephrosia species that exhibits potent inhibitory activity against the Dengue virus (DENV) in vitro. Its primary mechanism involves interacting with the soluble ectodomain of the DENV type 2 (DENV2) Envelope (E protein), potentially blocking viral entry or membrane fusion. The presence of the prenyl group is considered essential for its biological potency, making it a valuable scaffold for flavivirus-targeted drug discovery.